ÂÜÀòÂÒÂ×

David Steinmiller is an accomplished business executive with extensive experience in the biotechnology and diagnostics sectors. Currently serving as Chief Business Officer, Board Member, and Advisor at HelixBind, Inc., since 2014, David also holds a Board Member position at Trilo Therapeutics and serves as Director Emeritus and Chair of the Board of Directors at HYPOTHEkids. Previously, David was COO of OPKO Diagnostics, overseeing in-vitro diagnostic product development, and was Founder and COO of Claros Diagnostics. David's early career includes a role as Director of Engineering at Eos Biotechnology. David holds an MBA from MIT Sloan School of Management and advanced degrees in Mechanical Engineering from Stanford University.